Clinical Trial Update: Epoetin Alfa (Hemax®) Phase IV Study in Chemotherapy Induced Anemia [Phase 4]

View source ↗

Summary

A Phase IV trial evaluating epoetin alfa (Hemax) for chemotherapy-induced anemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Anemia

Drugs mentioned

• Hemax (epoetin alfa)

Snippet

Sponsor: Bio Sidus SA | Conditions: Antineoplastic Chemotherapy Induced Anemia | Phase 4 | Status: COMPLETED